NO990450L - Behandling av sinnslidelser - Google Patents

Behandling av sinnslidelser

Info

Publication number
NO990450L
NO990450L NO990450A NO990450A NO990450L NO 990450 L NO990450 L NO 990450L NO 990450 A NO990450 A NO 990450A NO 990450 A NO990450 A NO 990450A NO 990450 L NO990450 L NO 990450L
Authority
NO
Norway
Prior art keywords
treatment
mental disorders
tiagabine
medicament
manufacture
Prior art date
Application number
NO990450A
Other languages
English (en)
Norwegian (no)
Other versions
NO990450D0 (no
Inventor
Anders Fink-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO990450D0 publication Critical patent/NO990450D0/no
Publication of NO990450L publication Critical patent/NO990450L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO990450A 1996-07-31 1999-01-29 Behandling av sinnslidelser NO990450L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK82496 1996-07-31
PCT/DK1997/000320 WO1998005330A1 (en) 1996-07-31 1997-07-25 Treatment of psychotic disorders

Publications (2)

Publication Number Publication Date
NO990450D0 NO990450D0 (no) 1999-01-29
NO990450L true NO990450L (no) 1999-01-29

Family

ID=8097971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990450A NO990450L (no) 1996-07-31 1999-01-29 Behandling av sinnslidelser

Country Status (18)

Country Link
US (1) US5914333A (de)
EP (1) EP0920316B1 (de)
JP (1) JP2000515156A (de)
KR (1) KR20000029525A (de)
CN (1) CN1226828A (de)
AT (1) ATE330604T1 (de)
AU (1) AU728191B2 (de)
BR (1) BR9710893A (de)
CA (1) CA2260863C (de)
CZ (1) CZ29899A3 (de)
DE (1) DE69736180T2 (de)
ES (1) ES2268732T3 (de)
HU (1) HUP9904030A3 (de)
IL (1) IL128028A0 (de)
NO (1) NO990450L (de)
PL (1) PL331321A1 (de)
WO (1) WO1998005330A1 (de)
ZA (1) ZA976854B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
JP2001511450A (ja) * 1997-08-01 2001-08-14 エラン コーポレーシヨン ピーエルシー チアガビンを含有する制御放出性の医薬組成物
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
DE60022692T2 (de) * 1999-07-01 2006-06-22 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
US6270438B1 (en) * 1999-12-22 2001-08-07 Yuan-Cheng Liao Combination driving hub for bicycle
JP2004502664A (ja) 2000-06-30 2004-01-29 イーラン　ファーマスーティカルズ、インコーポレイテッド アルツハイマー病処置用化合物
US20050070524A1 (en) * 2003-06-06 2005-03-31 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
NZ307159A (en) * 1995-05-05 1998-10-28 Novo Nordisk As Medicament containing tiagabine, antioxidant, and carrier
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DK174041B1 (da) * 1998-11-26 2002-05-06 Monarflex As Gennemføring til montering i en fleksibel membran

Also Published As

Publication number Publication date
WO1998005330A1 (en) 1998-02-12
HUP9904030A3 (en) 2000-07-28
ES2268732T3 (es) 2007-03-16
DE69736180T2 (de) 2007-06-14
EP0920316A1 (de) 1999-06-09
DE69736180D1 (de) 2006-08-03
HUP9904030A2 (hu) 2000-05-28
IL128028A0 (en) 1999-11-30
KR20000029525A (ko) 2000-05-25
EP0920316B1 (de) 2006-06-21
JP2000515156A (ja) 2000-11-14
BR9710893A (pt) 1999-08-17
US5914333A (en) 1999-06-22
AU728191B2 (en) 2001-01-04
AU3619797A (en) 1998-02-25
CZ29899A3 (cs) 1999-06-16
NO990450D0 (no) 1999-01-29
ATE330604T1 (de) 2006-07-15
PL331321A1 (en) 1999-07-05
ZA976854B (en) 1998-03-19
CN1226828A (zh) 1999-08-25
CA2260863C (en) 2008-02-12
CA2260863A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
NO20010882D0 (no) Terapier for behandling av lungesykdommer
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
NO986051L (no) Anvendelsen av topiramat eller derivater derav for fremstilling av et medikament for behandling av manisk depressive, bipolare forstyrrelser
IL128416A0 (en) Pharmaceutical composition for the treatment of alzheimer's disease
DK0932398T3 (da) Anvendelse af topiramat eller derivater deraf til fremstilling af et lægemiddel til behandling af maniodepressive bipolære forstyrrelser
DE59310327D1 (de) Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
LV11666A (lv) Farmaceitiskie preparati un medikamenti endotelialo traucejumu noversanai un arstesanai
NO990450L (no) Behandling av sinnslidelser
EP1126850A4 (de) Behandlung von retinalerkrankungen
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
PT1007040E (pt) Utilizacao de fanquinona no tratamento da doenca de alzheimer
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
DE69738320D1 (de) Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch
LV11940A (lv) Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas
BR0008703A (pt) Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application